<DOC>
	<DOCNO>NCT02628483</DOCNO>
	<brief_summary>The health benefit omega-3 fatty acid extensively examine many publish study , benefit observe patient diversity condition disease , include cardiovascular disease ( e.g . atrial fibrillation , atherosclerosis , thrombosis , inflammation , sudden cardiac death , etc . ) , age-related cognitive decline , periodontal disease , rheumatoid arthritis , etc . These fatty acid may also beneficial healthy individual , term preventative health benefit . The balance omega-6 long chain fatty acid omega-3 counterpart important health maintenance . An omega-6 : omega-3 ratio 1:1 2:1 recommend optimal health , yet average ratio North American population estimate much 10:1 even 20:1 . A 2014 study dietary habit U.S. adult reveal , general , North Americans meet recommend omega-3 fatty acid intake food alone . Supplementation may need consider , order help population meet daily need . Both Academy Nutrition Dietetics American Heart Association suggest prudent approach recommend increased intake omega-3 fatty acid . Although organisation recommend preference obtain omega-3 fatty acid fish consumption , also recognise supplementation may also require order meet target value , particularly at-risk population . Several omega-3 fish oil supplement exist market ratio EPA DHA available vary form include ethyl ester high triglyceride form . Differences product formulation show vary health effect .</brief_summary>
	<brief_title>A Comparator Trial Relative Efficacy Two Triglyceride Forms Fish Oil</brief_title>
	<detailed_description />
	<criteria>Male female adult age 18 35 ( inclusive ) Healthy determine medical history Nonsmoker , exsmoker ≥6 month Body mass index 18.5 24.9 kg/m2 Female participant childbearing potential ( i.e . surgically sterilize postmenopausal great one year ) must negative urine pregnancy test must use effective birth control method Willing avoid alcohol consumption 24 h prior every clinic visit Willing maintain stable body weight , activity level dietary pattern except use study product , direct Willing able provide inform write consent Individuals take prescription nonprescription health product may affect study endpoint ( e.g . corticosteroid , prescription antiinflammatory drug , blood lipidlowering drug ( e.g . statin , fibrates , bile acid exchanger resin , phytosterols , niacin analogue , carnitine , etc . ) previous 6 month Individuals take supplement omega3 fatty acid , phytosterols , polyglucosamines ( Chitosan ) lipidbinding ingredient previous 6 month Individuals consume omega3 fatty acid rich fish ( salmon , mackerel , herring ) twice per month Unstable use ( initiation change dose ) antihypertensive medication thyroid hormone replacement medication within 3 month prior visit 1 Use weightloss program weightloss medication ( prescription overthe counter ) include , limited , lipase inhibitor , within 6 month prior visit 1 throughout study Pregnancy lactation , participant unwilling take appropriate contraceptive duration study History blood clot disorder use coagulationinhibiting drug ( e.g . warfarin ) Presence major disease diabetes , gastrointestinal , endocrine , cardiovascular , renal , liver disease History neurological disease ( e.g . Parkinson 's disease , stroke , traumatic brain injury , etc . ) History cancer ( exclude nonmelanoma skin cancer basal cell carcinoma ) past 5 year Uncontrolled hypertension define seat rest systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg Abnormal laboratory test result clinical significance , include , limited , ALT AST ≥1.5X upper limit normal screening ( visit 1 ) Triglycerides ≥400 mg/dL ( ≥4.52mmol/L ) screening ( visit 1 ) Presence history ( past 6 month ) alcohol drug abuse ; alcohol use &gt; 2 standard alcoholic drink per day Participant know allergy intolerance fish/fish oil ingredient test product Participant vegan Participant unwilling unable abide requirement protocol Any condition would interfere participant 's ability comply study instruction , might confound interpretation study , put participant risk Participant take investigational medicine participate research study within 30 day prior first study visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>